This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Sesamoiditis

Authoring team

This condition is due to arthritic changes of the surface of the sesamoids at their site of articulation with the plantar head of the first metatarsal

  • patients complain of pain, generally under the first metatarsal head during weight-bearing, and particularly when walking
    • often a patient will complain of pain under the metatarsal head as the weight is taken aound about 'toe-off'
  • a distinct plantar callosity may be detected clinically but will not be the only cause of localised tenderness; also there may be reduction in extension of the first MTP joint
  • similar pain may also be due to fracture or hypertrophy of the sesamoid

Treatment:

  • insoles with an aperture cut to raise the sesamoid off the bottom of the shoe and thus to afford relief via cushioning of the lesion; simple cushioning such as sorbothane insoles and silicone gels applied to the area can also help
  • steroid preparations injected directly into the sesamoid apparatus will also help reduce pain (1)

Reference:

  1. Rheumatic Disease in Practice (September 2001). The therapeutic scope of modern podiatry. Issue number 6, Arthritis Research Campaign.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.